This study found endocrine abnormalities in male schizophrenia patients, suggesting hypothalamic noradrenaline deficiency. Catecholamine agonists showed potential in improving symptoms and revealed genetically distinct dopamine receptor sensitivity groups.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: